K. Kameo

发表

In vitro and in vivo pharmacological profile of 5-[2-[4-(6-fluoro-1H-indole-3-yl)piperidin-1-yl]ethyl]-4-(4-fluorophenyl)thiazole-2-carboxylic acid amide (NRA0562), a novel and putative atypical antipsychotic.

S. Chaki, T. Funakoshi, R. Yoshikawa, 2002, Life sciences.

Overproduction of Thermus sp. YS 8-13 manganese catalase in Escherichia coli production of soluble apoenzyme and in vitro formation of active holoenzyme.

Y. Kawata, J. Nagai, T. Mizobata, 2000, European journal of biochemistry.

Effect of taurine on cholesterol metabolism in hamsters: up-regulation of low density lipoprotein (LDL) receptor by taurine.

Y. Toda, S. Murakami, M. Sakono, 2002, Life sciences.

Involvement of the hypothalamus–pituitary–adrenal axis in antidepressant activity of corticotropin-releasing factor subtype 1 receptor antagonists in the rat learned helplessness test

S. Chaki, A. Nakazato, N. Kawashima, 2001, Pharmacology Biochemistry and Behavior.

Discovery of a N'-hydroxyphenylformamidine derivative HET0016 as a potent and selective 20-HETE synthase inhibitor.

T. Ishii, M. Sato, N. Miyata, 2001, Bioorganic & medicinal chemistry letters.

Protective effects of SEA0400, a novel and selective inhibitor of the Na+/Ca2+ exchanger, on myocardial ischemia-reperfusion injuries.

A. Baba, T. Matsuda, Teisuke Takahashi, 2003, European journal of pharmacology.

Effects of taurine on serum cholesterol levels and development of atherosclerosis in spontaneously hyperlipidaemic mice

S. Murakami, Y. Matsushima, M. Tachibana, 2003, Clinical and experimental pharmacology & physiology.

Stereochemical studies. XLVII. Asymmetric reduction of 2-alkyl-1,3,4-cyclopentanetriones with lithium aluminum hydride decomposed by optically active .BETA.-aminoalcohols. Syntheses of optically active allethrolone and prostaglandin E1.

S. Terashima, K. Kameo, M. Kitamoto, 1977 .

Neuropharmacological profiles of a novel atypical antipsychotic, NRA0562, in rats.

S. Chaki, T. Funakoshi, S. Okuyama, 2001, European journal of pharmacology.

Pyrazole and isoxazole derivatives as new, potent, and selective 20-hydroxy-5,8,11,14-eicosatetraenoic acid synthase inhibitors.

Toshio Nakamura, H. Kakinuma, N. Miyata, 2003, Journal of medicinal chemistry.

SEA0400, a novel and selective inhibitor of the Na+-Ca2+ exchanger, attenuates reperfusion injury in the in vitro and in vivo cerebral ischemic models.

T. Suzuki, A. Baba, T. Matsuda, 2001, The Journal of pharmacology and experimental therapeutics.

Synthesis and structure-activity relationships of a new class of selective EP3 receptor agonist, 13,14-didehydro-16-phenoxy analogues of prostaglandin E1.

S. Okamoto, F. Sato, Y. Shimazaki, 2000, Bioorganic & medicinal chemistry.

Synthesis and pharmacological activities of 13-dehydro derivatives of primary prostaglandins.

S. Okamoto, N. Ono, F. Sato, 1998, Bioorganic & medicinal chemistry letters.

HET0016, a potent and selective inhibitor of 20‐HETE synthesizing enzyme

N. Miyata, Masakazu Sato, K. Taniguchi, 2001, British journal of pharmacology.

Synthesis and antibacterial activity of acylides (3-O-acyl-erythromycin derivatives): a novel class of macrolide antibiotics.

A. Nishida, K. Suzuki, M. Sato, 2001, Journal of medicinal chemistry.

Synthesis and antibacterial activity of a novel series of acylides: 3-O-(3-pyridyl)acetylerythromycin A derivatives.

A. Nishida, Masakazu Sato, Hiroyuki Sugiyama, 2003, Journal of medicinal chemistry.

Structure-activity studies of 3-benzoylpropionic acid derivatives suppressing adjuvant arthritis.

K. Tomisawa, S. Hirono, I. Moriguchi, 1992, Chemical & pharmaceutical bulletin.

Immunopharmacological studies of new 3-benzoyl-4-mercaptobutyric acids. Immunomodulating effects.

K. Tomisawa, H. Aihara, S. Otomo, 1988, Arzneimittel-Forschung.

Studies on antirheumatic agents: 3-benzoylpropionic acid derivatives.

K. Tomisawa, S. Nakaike, K. Kameo, 1988, Chemical & pharmaceutical bulletin.

Studies on Antirheumatic Agents: 3‐Benzoylpropionic Acid Derivatives.

K. Tomisawa, S. Nakaike, K. Kameo, 1989 .

Increase in secretion of glial cell line-derived neurotrophic factor from glial cell lines by inhibitors of vacuolar ATPase

S. Chaki, S. Okuyama, Y. Nozawa, 2003, Neurochemistry International.

Taurine Inhibits Development Of Atherosclerotic Lesions In apolipoprotein E‐Deficient Mice‡

S. Murakami, H. Kitajima, K. Kameo, 2001, Clinical and experimental pharmacology & physiology.

Involvement of corticotropin-releasing factor subtype 1 receptor in the acquisition phase of learned helplessness in rats.

S. Chaki, A. Nakazato, N. Kawashima, 2001, Life sciences.